5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The evolution of bladder cancer treatment: Improvements in clinical management, enhanced clinical outcomes, and targeting newly identified molecular alterations
    Journal Article

    Bajorin, D. F.
    Seminars in Oncology (2007)

    Fulltext@MSK | Save
  • The graying of testis cancer patients: What have we learned?
    Journal Article

    Bajorin, D. F.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Renal cancer pathology and prognostic factors
    Book Section

    Reuter, V. E.; Russo, P.; Motzer, R. J.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Debruyne, F. M. J.; Linehan, W. M. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 3rd ed (2006)

    Fulltext@MSK | Save
  • Management and treatment of poor prognosis and relapsed germ cell tumors
    Book Section

    Kondagunta, G. V.; Bosl, G. J.; Motzer, R. J.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Debruyne, F. M. J.; Linehan, W. M. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 3rd ed (2006)

    Fulltext@MSK | Save
  • Chemotherapy for metastatic bladder, alone or in combination with other treatment
    Book Section

    Galsky, M. D.; Bajorin, D. F.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Debruyne, F. M. J.; Linehan, W. M. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 3rd ed (2006)

    Fulltext@MSK | Save
  • Beyond first-line hormones: Options for treatment of castration-resistant disease
    Book Section

    Beekman, K.; Tilley, W. D.; Buchanan, G.; Scher, H. I.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Debruyne, F. M. J.; Linehan, W. M. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 3rd ed (2006)

    Fulltext@MSK | Save
  • Tumor-specific serum peptidome patterns
    Meeting Abstract

    Tempst, P.; Villanueva, J.; Shaffer, D. R.; Martorella, A.; Robson, M. E.; Lawlor, K.; Philip, J.; Fleisher, M.; Lilja, H.; Holland, E. C.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • FLT PET as a non-invasive marker of response to MEK inhibition
    Meeting Abstract

    Solit, D. B.; Santos, E.; Pratilas, C. A.; Moroz, M.; Blasberg, R.; Sebolt-Leopold, J.; Larson, S.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of P13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y.; Solit, D. B.; Rosen, N.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • MAPK activation by B-RAF mutation or tyrosine kinase activation is associated with different patterns of feedback regulation that correlate with functional output of the pathway
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Sebolt-Leopold, J.; Rosen, N.; Solit, D. B.
    Cancer Research (2006)

    Fulltext@MSK | Save